https://www.indianpharmapost.com/dgci-green-lights-biological-e-for-phase-23-trials-of-its-covid-19-vaccine-candidate-for-children-101572021-09-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/indigenous-technology-will-help-reduce-dependence-on-imports-dr-singh-101582021-09-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/omeza-collegen-matrix-gets-us-fda-approval-101592021-09-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-announces-phase-3-clinical-trial-for-vaccine-against-respiratory-syncytial-virus-rsv-101602021-09-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/covid-19-vaccine-clinical-trial-for-people-with-autoimmune-disease-101612021-09-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/novartis-signs-worlds-first-agreement-with-nhs-uk-101622021-09-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/cii-awards-excellence-in-energy-efficiency-to-sai-life-sciences-api-unit-101632021-09-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/digital-adoption-in-healthcare-will-see-exponential-growth-wipro-ge-study-101642021-09-03T00:00:00+05:30always0.9